These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8858281)

  • 1. Bioavailability of ciprofloxacin in patients with acute infectious diarrhoe.
    Beckebaum S; Bircher J; Gallenkamp H
    Eur J Clin Pharmacol; 1996; 50(6):511-2. PubMed ID: 8858281
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative bioavailability of two oral formulations of ciprofloxacin.
    Trejo D; Toledo A; Carrasco-Portugal Mdel C; Aguilar-Cota ME; Herrera JE; Flores-Murrieta FJ
    Proc West Pharmacol Soc; 2003; 46():134-5. PubMed ID: 14699910
    [No Abstract]   [Full Text] [Related]  

  • 3. Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients.
    Müller M; Brunner M; Hollenstein U; Joukhadar C; Schmid R; Minar E; Ehringer H; Eichler HG
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2056-8. PubMed ID: 10428936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates.
    Khan MK; Khan MF; Khan H; Mustafa G
    Pak J Pharm Sci; 2009 Jul; 22(3):329-34. PubMed ID: 19553184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chloroquine on the bioavailability of ciprofloxacin in man.
    Ilo EC; Orisakwe OE; Ilondu NA; Okwoli N; Brown SA; Elo-Ilo J; Agbasi PU
    J Control Release; 2006 Nov; 116(2):e109-10. PubMed ID: 17718943
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of omeprazole on bioavailability of an oral extended-release formulation of ciprofloxacin.
    Washington C; Hou E; Hughes N; Berner B
    Am J Health Syst Pharm; 2006 Apr; 63(7):653-6. PubMed ID: 16554289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin--clincal and pharmacokinetic studies in ear, nose and throat infections.
    Federspil P; Koch A; Tiesler E
    J Chemother; 1989 Jul; 1(4 Suppl):556-8. PubMed ID: 16312530
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of milk components, especially of casein, on the bioavailability of ciprofloxacin tablets cannot be evaluated by dissolution testing.
    Simon Z
    J Pharm Biomed Anal; 2010 Nov; 53(3):819; author reply 819-20. PubMed ID: 20457501
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics and burn eschar penetration of intravenous ciprofloxacin in patients with major thermal injuries.
    Varela JE; Cohn SM; Brown M; Ward CG; Namias N; Spalding PB
    J Antimicrob Chemother; 2000 Mar; 45(3):337-42. PubMed ID: 10702553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin bioavailability is enhanced by oral co-administration with phenazopyridine: a pharmacokinetic study in a Mexican population.
    Marcelín-Jiménez G; Angeles AP; Martínez-Rossier L; Fernández S A
    Clin Drug Investig; 2006; 26(6):323-8. PubMed ID: 17163266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of ciprofloxacin and fleroxacin: results of a preliminary investigation in healthy adult Nigerian male volunteers.
    Chukwuani CM; Coker HA; Oduola AM; Sowunmi A; Ifudu ND
    Biol Pharm Bull; 2000 Aug; 23(8):968-72. PubMed ID: 10963305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and milk penetration of orbifloxacin after intravenous and intramuscular injections to dromedary lactating camels (Camelus dromedaries).
    Goudah A; Abo-El-Sooud K
    J Vet Pharmacol Ther; 2008 Jun; 31(3):276-80. PubMed ID: 18471152
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of lanthanum carbonate on the absorption and oral bioavailability of ciprofloxacin.
    How PP; Fischer JH; Arruda JA; Lau AH
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1235-40. PubMed ID: 17913970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence evaluation of 2 different oral formulations of ciprofloxacin in healthy volunteers.
    Galicia I; Frias-Iniesta J; Carcas AJ; Soto A; Gomez E; Miranda E; Fernandez A; Montuenga C
    Int J Clin Pharmacol Ther; 1998 May; 36(5):282-5. PubMed ID: 9629993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative bioavailability of two brands of ciprofloxacin.
    Seth SD; Beotra A; Seth S
    J Assoc Physicians India; 1995 May; 43(5):327-30. PubMed ID: 9081961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinolones in dermatology.
    Sable D; Murakawa GJ
    Dis Mon; 2004 Jul; 50(7):381-94. PubMed ID: 15280869
    [No Abstract]   [Full Text] [Related]  

  • 17. Aqueous and vitreous penetration of topically applied ciprofloxacin and ofloxacin.
    Taustine LR
    J Cataract Refract Surg; 2004 Jan; 30(1):6. PubMed ID: 14967251
    [No Abstract]   [Full Text] [Related]  

  • 18. A prospective, open-label study of single-dose ciprofloxacin absorption after chemotherapy in patients with malignancy.
    Gattis WA; Petros WP; Pickard WW; Drew RH; May DB; Hathorn JW
    Pharmacotherapy; 1997; 17(4):836-40. PubMed ID: 9250569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of two balanced salt solutions on the bioavailability of ofloxacin and ciprofloxacin.
    Osato MS
    Adv Ther; 1999; 16(5):200-9. PubMed ID: 10915395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential or switch treatment - which criteria should be fulfilled?
    Shah PM
    Int J Antimicrob Agents; 2000 Nov; 16(3):301-2. PubMed ID: 11091052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.